P3028 – Mechanism of Action
Based on the knowledge of the P3028 mechanisms, CanImGuide had the additional advantage of being able to also develop several novel biomarkers to predict the treatment responses to various immuno-oncology drugs. This is possible, as the intra-tumor presence of P3028 seems to be a common component in cancers of vastly different types.